The clinical research pipeline is critical to ensuring continued development of novel treatments that can offer patients with cancer safe and effective options. Unfortunately, progress has slowed since the COVID-19 pandemic due to uncovered, systemic inefficiencies across critical processes. Towards initiating discussion on how to reinvigorate clinical research, the Society for Immunotherapy of Cancer (SITC) hosted a virtual summit that characterized issues and formed potential solutions. This commentary serves to highlight the crisis facing clinical research as well as stimulate field-wide discussion on how to better serve patients into the future.
CITATION STYLE
Hong, D. S., Lorusso, P., & Sznol, M. (2024, July 11). A crisis in clinical research. Journal for ImmunoTherapy of Cancer. BMJ Publishing Group. https://doi.org/10.1136/jitc-2023-008520
Mendeley helps you to discover research relevant for your work.